Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Cencora Q1 FY2026 Earnings Call - One Oncology Buyout Boosts Operating Income Guidance While Raising Interest Expense and Pausing Buybacks
Cencora reported a solid start to fiscal 2026 with adjusted diluted EPS of $4.08, consolidated revenue of $85.9 billion (up 5.5%), and consolidated operating income up 12%. Management closed its major...
- Cencora completed acquisition of majority stake in One Oncology, increasing ownership from 35% to 92%; remaining 8% held by practices and management.
- Company raised fiscal 2026 consolidated revenue guidance to 7%–9% (previously 5%–7%) and reaffirmed adjusted diluted EPS range of $17.45–$17.75.
- Consolidated operating income guidance was raised to 11.5%–13.5% growth, driven primarily by US Healthcare Solutions, where operating income guidance rose to 14%–16%.
- +13 more takeaways
Chubb Q4 2025 Earnings Call - Record underwriting, investment and life income lift core operating results to all-time highs
Chubb closed 2025 with a clean, broad-based beat. The company reported record fourth-quarter and full-year core operating income, driven by exceptionally strong P&C underwriting, record investment inc...
- Chubb delivered record Q4 and full-year core operating income, with the full-year core operating income just shy of $10 billion and $24.79 per share reported for 2025.
- Q4 core operating income was nearly $3 billion; P&C underwriting income for the quarter rose 40% to $2.2 billion and the quarterly combined ratio was a record-low 81.2%.
- Total company net premiums grew almost 9% in the quarter (P&C up 7.7%, Life up ~17%), and full-year total premiums grew over 6.5% (P&C ~5.5%, Life >15%).
- +15 more takeaways
Silgan Holdings Q4 2025 Earnings Call - Weener Integration Complete, Dispensing Now Majority of EBITDA, Guides to $3.70-$3.90 EPS
Silgan closed 2025 with solid operating results, a fully integrated Weener acquisition and a portfolio that is visibly shifting toward higher-margin dispensing products. Q4 sales were about $1.5 billi...
- Q4 2025 net sales approximately $1.5 billion, up 4% year over year driven by raw material pass-throughs and FX translation.
- Total adjusted EBIT for Q4 was $150.6 million, essentially flat versus the prior year; adjusted EPS was $0.67, down $0.18 driven by higher interest and a higher tax rate in the quarter.
- Dispensing and Specialty Closures (DSC) delivered record sales, adjusted EBIT and adjusted EBITDA in 2025, and now represents over 50% of company adjusted EBITDA.
- +12 more takeaways
IAC Q4 2025 Earnings Call - People Inc's off‑platform pivot cushions Google traffic losses, but Google litigation and print weakness keep consolidated EBITDA range muted
IAC closed 2025 with People Inc powering the quarter: digital revenue grew 14% in Q4 and the company is visibly succeeding at shifting audiences and advertisers off the traditional web. Non-session-ba...
- People Inc. digital revenue grew 14% in Q4, capping a year with $1.8 billion total revenue and $1.1 billion of digital revenue (digital up 10% for 2025).
- Core sessions declined 13% year-over-year in Q4, driven largely by a roughly 50% drop in Google Search referrals over two years and softness in Google Discover.
- Off-platform and distributed audiences are scaling: off-platform views nearly doubled over two years and grew 43% year-over-year in Q4. Non-session-based revenue now makes up about 38% of digital revenue and grew 37% year-over-year in Q4.
- +12 more takeaways
Twin Disc Inc. Fiscal Q2 2026 Earnings Call - Record Backlog Masks Tariff Pain, Defense Pipeline Accelerates
Twin Disc posted $90.2 million in Q2 revenue, roughly flat year over year, but organic sales fell about 7.9% after adjusting for M&A and FX. The quarter was shaped by tariff-driven customer timing, sh...
- Revenue: Q2 sales were $90.2 million, up 0.3% year over year, but organic revenue fell about 7.9% after adjusting for M&A and foreign exchange.
- Backlog: Record backlog of $175.3 million, up 41.4% year over year and up 7% sequentially, providing visibility into H2 fiscal 2026.
- Defense: Defense-related backlog rose 18% sequentially; management cites a defense pipeline north of $50 million driven by naval unmanned vessels and NATO land vehicle programs.
- +12 more takeaways
Azenta FQ1 2026 Earnings Call - Turnaround Intact, But Automated Stores Quality Hits Margins; H2 Acceleration Expected
Azenta says the turnaround is real, but the first quarter looks like a classic mid-course stumble. Reported revenue was $149 million, essentially flat organically (-1%) with margin pressure from under...
- Total revenue for Q1 FY2026 was $149 million, up 1% reported and down ~1% organically, with a 2% FX headwind.
- Gross margin declined to 44.1% in Q1, a 360 basis-point drop year-over-year, driven by underutilized North America lab capacity and rework costs on Automated Stores projects.
- Adjusted EBITDA was $13 million, an 8.5% margin, down roughly 230 basis points year-over-year; non-GAAP EPS was $0.09 for the quarter.
- +11 more takeaways
Atmos Energy Q1 FY2026 Earnings Call - Rebased Guidance After Texas HB 4384; Q1 EPS $2.44 on $1B Capex Focused on Safety
Atmos Energy reported a resilient start to fiscal 2026, posting net income of $403 million, or $2.44 per diluted share, while investing roughly $1 billion in the quarter with more than 85% directed to...
- Q1 FY2026 net income was $403 million, or $2.44 per diluted share, a 9.4% year over year increase.
- Company spent approximately $1.0 billion in Q1, with over 85% of capex allocated to distribution, transmission, and underground storage safety and reliability upgrades.
- Rebased FY2026 EPS guidance remains $8.15 to $8.35 after considering Texas House Bill 4384.
- +12 more takeaways
Weatherford International Q4 2025 Earnings Call - Q4 cash conversion spikes after Mexico collections
Weatherford closed 2025 on firmer footing, powering a Q4 surge in free cash flow that the company says validates its operating reset. Q4 adjusted free cash flow was $222 million, a 76% conversion, and...
- Q4 adjusted free cash flow was $222 million, representing a 76.3% adjusted free cash flow conversion for the quarter.
- Full‑year 2025 adjusted free cash flow totaled $466 million, a 43.7% conversion, materially higher than 2024.
- Q4 adjusted EBITDA margin was 22.6%, up about 74 basis points sequentially, reflecting cost actions and mix improvement.
- +13 more takeaways
Novartis Q4 2025 Earnings Call - Hit 40% Core Margin Early, Navigating Largest Ever 2026 Patent Cliff
Novartis closed 2025 with steady top-line momentum and a financial reset that will define 2026. The company delivered 8% sales growth and 14% core operating income growth for the year, reaching a 40.1...
- Full-year 2025: sales +8% and core operating income +14%, achieving a 40.1% core margin two years ahead of plan (CHF 21.9 billion core operating income).
- Record free cash flow of CHF 17.6 billion in 2025, enabling continued R&D investment, buybacks and dividend growth.
- Q4 2025 was down 1% in sales and core operating income up 1%, but underlying Q4 sales would have been +3% excluding out-of-period US R&D/gross-to-net adjustments tied to generics and Entresto LOE.
- +12 more takeaways
Fox Corporation Q2 FY2026 Earnings Call - Advertising strength and streaming scale mask rising costs
Fox reported steady top-line momentum driven by an advertising rebound across news, sports, and streaming, and accelerating streaming scale at Tubi and the newly launched FOX One. Total revenue was up...
- Total company revenue of $5.18 billion, up 2% year over year for Q2 FY2026.
- Adjusted EBITDA declined to $692 million from $781 million a year ago, driven by higher expenses tied to sports rights and digital growth initiatives.
- Net income attributable to shareholders was $229 million, or $0.52 per share, versus $373 million, or $0.81, in the prior year; adjusted EPS was $0.82.
- +17 more takeaways